Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies

Author:

Sun Ting1,Wang Yuchen1,Song Xiaoyu1,Li Ruili2,Mei Fanghua3,Yang Mengliu1,Huang Xiaojie4,Li Yan5ORCID,Zhou Xuwei1,Wang Haoyu1,Li Wendong1,Li Jing1,Wang Lu1,Shi Wei1,Cai Kun3,Li Hongjun6,Zhang Jing1ORCID

Affiliation:

1. Key Laboratory for Biomechanics and Mechanobiology of the Ministry of Education, Beijing Advanced Innovation Centre for Biomedical Engineering, School of Engineering Medicine, Beihang University, Beijing, China

2. Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China

3. Hubei Center for Disease Control and Prevention, Wuhan, China

4. Clinical and Research Center for Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China

5. Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

6. Department of Radiology, Beijing You An Hospital, Capital Medical University, Beijing, China

Abstract

Our study illustrates the immune responses engaged by encountering antigen, highlighting the critical roles of B-cell activating humoral immunity in the body’s antibody production.

Funder

Youth Thousand Scholar Program of China

Program for High-Level Overseas Talents, Beihang University

Young Talent Investigator Grant

Beijing YouAn Hospital Project for COVID-19

Beijing Excellent Talent Plan

Beijing National Science Foundation

YouAn Medical Development Project of COVID-19 Emergency Prevention and Control Public

Beijing Natural Science Foundation

MOST | National Key Research and Development Program of China

National Natural Science Foundation of China

Chinese Institute for Brain Research

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3